Bridging institutions: the role of contract research organisations in technology transfer

1994 ◽  
Keyword(s):  
Technology Transfer ◽  
Contract Research ◽  
Research Organisations ◽  
Contract Research Organisations

scholarly journals Promoting Australian industry: CSIRO 1949–79

2019 ◽  
Vol 30 (1) ◽  
pp. 1 ◽  
Author(s):  
Garrett Upstill
Keyword(s):  
Technology Transfer ◽  
Public Research ◽  
Research Organisation ◽  
Economic Climate ◽  
New Thinking ◽  
Research Organisations ◽  
Rural Industries ◽  
Political Scene ◽  
Australian Industry

This paper addresses the manner in which the Commonwealth Scientific and Industrial Research Organisation (CSIRO) transferred its technology to Australian industry during the period 1949 to 1979. The analysis is framed within the changing economic and political scene in Australia and the changing expectations for public research organisations such as CSIRO. During the 1950s and 1960s CSIRO gave little direct attention to the processes of technology transfer but instead, following the prevailing wisdom, focused on high quality science and relied on existing extension services and patenting to capture the benefits from its research. This ‘science-push’ approach proved successful for Australia’s rural industries but, with a few exceptions, less so for the country’s secondary industries. By the early 1970s CSIRO faced pressures for change, induced by a tougher economic climate and changing views on the role of public research institutions. A shift toward greater customer relevance in its research would also need to be matched by new thinking about technology transfer.

Practical issues in conducting multinational, multicenter trials managed by Contract Research Organisations

1994 ◽  
Vol 9 (3) ◽  
pp. 151-153
Author(s):  
M Placchi
Keyword(s):  
Drug Therapy ◽  
Therapeutic Agent ◽  
Clinical Development ◽  
Phase Iii ◽  
Contract Research ◽  
Multicenter Trials ◽  
Practice Organization ◽  
Research Organisations ◽  
Joint Evaluation ◽  
Contract Research Organisations

Large multinational, multicenter trials are increasingly being performed during Phase III of the clinical development of a psychotropic drug to demonstrate the efficacy of the new therapeutic agent in the shortest possible time. The testing of the new drug therapy under a common protocol, foreseeing the combination of clinical data collected across countries for a joint evaluation, is becoming more frequent in drug development. Usually, Sponsors use the services of Contract Research Organisations (CROs) to undertake and manage such large multinational, multicenter trials.The Sponsor who is setting up large definitive CRO-managed studies with psychotropics may anticipate to encounter issues along the following lines: Psychiatric Practice, Organization and Logistics, Data Integration and Manpower.

scholarly journals Big-pharmaceuticalisation: Clinical trials and Contract Research Organisations in India

2015 ◽  
Vol 131 ◽  
pp. 239-246 ◽  
Author(s):  
Salla Sariola ◽  
Deapica Ravindran ◽  
Anand Kumar ◽  
Roger Jeffery
Keyword(s):  
Clinical Trials ◽  
Contract Research ◽  
Research Organisations ◽  
Contract Research Organisations

scholarly journals Putting contract research organisations on the radar

2012 ◽  
Vol 9 (2) ◽  
pp. 32-34
Author(s):  
Mariëtte van Huijstee ◽  
Nuria Homedes
Keyword(s):  
Clinical Trials ◽  
Third Parties ◽  
Pharmaceutical Companies ◽  
Middle Income ◽  
Contract Research ◽  
Middle Income Countries ◽  
Research Organisations ◽  
Contract Research Organisations ◽  
Low And Middle Income

There is a trend for pharmaceutical companies to contract third parties to conduct the clinical trials that are needed to test their drugs. This trend is referred to as outsourcing, and the companies that carry out the work are called contract research organisations. In addition, clinical trials are increasingly conducted in non-traditional trial regions, which are mainly low-and middle-income countries. This trend is called offshoring. The combination of outsourcing and offshoring poses serious risks for the ethical treatment of participants in clinical trials.

Sign in / Sign up

Export Citation Format

Share Document